Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
Idexx Laboratories Inc (IDXX) has a market cap of $46.39B with year-over-year revenue growth of +10.4%. Net margin stands at 24.6%. The stock trades at a P/E ratio of 43.8.
Compared to other companies in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector, IDXX posted revenue growth of +10.4% and trades at a P/E of 43.8.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.